Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 15/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 14/20 | 0.47 |
| ▸ | PPARG | P37231 | 14/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7041631 | 0.86 | PPARA (0.53) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL7040389 | 0.85 | NR1H2 (0.48) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL1401077 | 0.83 | NR1H3 (0.71) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL6100087 | 0.82 | GRM2 (0.63) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL6101419 | 0.82 | PPARA (0.68) | PPARDPPARAPPARG | |
| SCHEMBL6102222 | 0.80 | NR1H2 (0.70) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL7040761 | 0.79 | PPARA (0.73) | PPARDPPARAPPARG | |
| SCHEMBL13597386 | 0.77 | PPARD (0.44) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL1400270 | 0.77 | NR1H3 (0.66) | PPARDNR1H2NR1H3PPARAPPARG | |
| SCHEMBL7041390 | 0.76 | PPARA (0.67) | PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882029-B1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6090836-A | DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION | MERCK & CO., INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |